Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 8Colorectal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Prostatic Neoplasms 3Neoplasms 3Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Motor Activity 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Colonic Neoplasms 2Wilms Tumor 1Venous Thromboembolism 1Uveal Melanoma 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Opioid-Related Disorders 1Neuroblastoma 1Neoplastic Cells, Circulating 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia 1Inflammation 1Hodgkin Disease 1Hepatic Veno-Occlusive Disease 1HPV Positive Oropharyngeal Squamous Cell Carcinoma 1Fibrosis 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Hematologic Tests × Clear all
NCT06346054 2026-02-17

MAGEC

KU Leuven

Phase NA Recruiting
1,000 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

NCT00580281 2013-10-24

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Completed
33 enrolled
GastrointestinalMyeloidOther hematologic neoplasm

Leukemia, Stomach Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡